Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant therapy in rectal cancer.

A M Cohen1

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Hepato-Gastroenterology
|June 1, 1992
PubMed
Summary

Adjuvant pelvic radiation and chemotherapy significantly reduce rectal cancer recurrence after surgery. Ongoing trials explore optimal treatment combinations to improve patient outcomes and prevent distant metastases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fixing the problem.

British dental journal·2003
Same author

On the mechanism of post-splenectomy leukocytosis in mice.

European journal of clinical investigation·2003
Same author

Results after rectal cancer resection with in-continuity partial vaginectomy and total mesorectal excision.

Annals of surgical oncology·2003
Same author

Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified?

Annals of surgical oncology·2003
Same author

Classification of lymphoproliferative disorders by spectral imaging of the nucleus.

Histology and histopathology·2002
Same author

Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers.

International journal of colorectal disease·2002

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Local recurrence in the pelvis after rectal cancer surgery leads to significant morbidity.
  • Pelvic recurrence affects 25% of rectal cancer patients, often with poor response to further treatment.
  • Effective strategies are needed to reduce local failure and prevent distant spread.

Purpose of the Study:

  • To highlight the efficacy of adjuvant pelvic radiation therapy and systemic chemotherapy in preventing rectal cancer recurrence.
  • To discuss the current research landscape focusing on optimizing multimodal treatment strategies.
  • To underscore the importance of reducing local pelvic failure and subsequent distant metastases.

Main Methods:

  • Review of current clinical evidence on adjuvant therapy for rectal cancer.
  • Analysis of the impact of combined radiation and chemotherapy on local recurrence rates.
  • Examination of ongoing clinical trials investigating treatment interactions and chemotherapy regimens.

Main Results:

  • Adjuvant pelvic radiation therapy combined with systemic chemotherapy is effective in decreasing local recurrence.
  • This combined approach also reduces the incidence of distant metastases.
  • Current research focuses on refining these multimodal treatment strategies.

Conclusions:

  • Combined adjuvant pelvic radiation and chemotherapy represent a crucial strategy for improving outcomes in rectal cancer patients.
  • Further research and clinical trials are essential to optimize treatment protocols and enhance patient survival.
  • Minimizing pelvic recurrence is key to preventing the development of distant metastases.

Related Experiment Videos